Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Total Terapi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.7% 3.6% 4.4% 5.4% 2.6% 10.9% 18.3% 17.9%   Credit score (0-100)   62 54 49 43 60 21 7 7   Credit rating   BBB BBB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   830 562 538 494 379 76.8 0.0 0.0   EBITDA   245 33.0 52.0 374 347 -195 0.0 0.0   EBIT   233 12.0 31.0 347 265 -195 0.0 0.0   Pre-tax profit (PTP)   158.0 -55.0 -34.0 139.0 263.8 -196.4 0.0 0.0   Net earnings   126.0 -43.0 -27.0 103.0 205.9 -202.4 0.0 0.0   Pre-tax profit without non-rec. items   158 -55.0 -34.0 139 264 -196 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Tangible assets total   1,950 1,929 1,910 267 392 392 0.0 0.0   Shareholders equity total   399 306 279 382 588 386 306 306   Interest-bearing liabilities   1,406 1,399 1,345 7.0 17.6 17.6 0.0 0.0   Balance sheet total (assets)   2,059 1,992 1,954 527 715 513 306 306   Net Debt   1,348 1,399 1,345 -107 -126 -56.5 -306 -306     See the entire balance sheet 1000.0 Volume  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   830 562 538 494 379 76.8 0.0 0.0   Gross profit growth   0.0% -32.3% -4.3% -8.2% -23.3% -79.7% -100.0% 0.0%   Employees   1 1 1 1 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,059 1,992 1,954 527 715 513 306 306   Balance sheet change%   0.0% -3.3% -1.9% -73.0% 35.7% -28.3% -40.3% 0.0%   Added value   233.0 12.0 31.0 347.0 264.6 -195.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   1,938 -42 -40 -1,670 42 0 -392 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.1% 2.1% 5.8% 70.2% 69.8% -254.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 0.6% 1.6% 28.0% 42.6% -31.8% 0.0% 0.0%   ROI %   12.9% 0.7% 1.9% 34.4% 52.1% -37.4% 0.0% 0.0%   ROE %   31.6% -12.2% -9.2% 31.2% 42.4% -41.6% 0.0% 0.0%   1000.0 Solidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Equity ratio %   19.4% 15.4% 14.3% 72.5% 82.3% 75.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   550.2% 4,239.4% 2,586.5% -28.6% -36.1% 28.9% 0.0% 0.0%   Gearing %   352.4% 457.2% 482.1% 1.8% 3.0% 4.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   10.7% 4.8% 4.7% 30.8% 7.0% 5.9% 0.0% 0.0%   1000.0 Liquidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Quick Ratio   0.3 0.1 0.1 1.8 2.9 1.1 0.0 0.0   Current Ratio   0.3 0.1 0.1 1.8 2.9 1.1 0.0 0.0   Cash and cash equivalent   58.0 0.0 0.0 114.0 143.1 74.0 0.0 0.0   1000.0 Capital use efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -206.0 -352.0 -413.0 119.0 213.6 11.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   233 12 31 347 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   245 33 52 374 0 0 0 0   EBIT / employee   233 12 31 347 0 0 0 0   Net earnings / employee   126 -43 -27 103 0 0 0 0